Non-alcoholic fatty liver disease (NAFLD) is an important public health problem with growing
numbers of NAFLD patients worldwide. Pathological conditions are different in each stage of …

Non-alcoholic fatty liver disease (NAFLD) has a global prevalence of approximately 25%
and is associated with high morbidity and high mortality. NAFLD is a leading cause of …

Recent studies have discovered that tiny particles of microplastics (MPs) at the nano-scale
level can enter the body of organisms from the environment, potentially causing metabolic …

NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) is an intracellular complex that
upon external stimuli or contact with specific ligands, recruits other components, forming the …

Background and aims In metabolic (dysfunction)-associated fatty liver disease (MAFLD),
activation of inflammatory processes marks the transition of simple steatosis to …

Acute liver failure (ALF) is a rare and serious condition characterized by major hepatocyte
death and liver dysfunction. Owing to the limited therapeutic options, this disease generally …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease,
seriously affecting human health. Carnosine, which widely exists in the skeletal muscle of …

Background Non-alcoholic fatty liver disease (NAFLD) is a prevalent chronic liver condition
with significant clinical implications. Emerging research indicates endoplasmic reticulum …

MAFLD stands for metabolic-related fatty liver disease, which is a prevalent liver disease
affecting one-third of adults worldwide, and is strongly associated with obesity …

Abstract Ethnopharmacological relevance Erhuang Quzhi Granules (EQG) is a compound
composed of 13 traditional Chinese medicines developed by the First Affiliated Hospital of …